As of 2023, the mortality from malignant neoplasms in Brazil stood at approximately 237.77 thousand deaths. Forecast data from 2024 to 2028 suggest a consistent increase in mortality, with an average year-on-year growth rate of about 1.2%. The compounded annual growth rate (CAGR) over these five years is projected to be approximately 1.2% as well, indicating a steady upward trend in malignant neoplasm-related deaths.
Looking forward, it will be crucial to monitor changes in healthcare policies, advancements in medical treatments, and cancer prevention initiatives, as these factors may significantly impact future mortality trends. Additionally, demographic shifts such as aging populations may further influence cancer mortality rates.
